References
- Goldstein G. Isolation of bovine thymin: A polypeptide hormone of the thymus. Nature 1974; 247: 11–14
- Basch R. S., Goldstein G. Induction of T-cell differentiation in vitro by thymin, a purified polypeptide hormone of the thymus. Proc. Natl. Acad. Sci. USA 1974; 71: 1474–1478
- Sunshine G. H., Basch R. S., Coffey R. G., Cohen K. W., Goldstein G., Hadden J. W. Thymopoietin enhances the allogeneic response and cyclic GMP levels of mouse peripheral, thymus-derived lymphocytes. J. Immunol. 1978; 120: 1594–1599
- Harris C. A., Andryuk P. J., Cline S., Chan H. K., Natarajan A., Siekierka J. J., Goldstein G. Three distinct thymopoietins are derived from alternatively spliced mRNAs. Proc. Natl. Acad. Sci. USA 1994; 91: 6283–6287
- Harris C. A., Andryuk P. J., Cline S., Mathew S., Siekierka J. J., Goldstein G. Structure and mapping of the human thymopoietin (TMPO) gene and relationship of human TMPO β to the rat lamin-associated polypeptide 2. Genomics 1995; 28: 198–205
- Furukawa K., Pante N., Aebi U., Gerace K. Cloning of a cDNA for lamina associated polypeptide 2 (LAP2) and identification of regions that specify targeting to the nuclear envelope. EMBO J. 1995; 14: 1626–1636
- Theodor L., Shoham J., Berger R., Gokkel E., Trachtenbrot L., Simon A. J., Nir U., Ilan E., Zevin-Sonkin D., Friedman E., Rechavi G. Ubiquitous expression of a cloned murine thymopoietin cDNA. Acta Haematologica 1997; 97: 153–163
- Goldstein G., Scheid M. P., Boyse E. A., Schlesinger D. H., Van Wauwe J. A synthetic pentapeptide with biological activity characteristic of the thymic hormone thymopoietin. Science 1979; 204: 1309–1310
- Malicevic Z., Kojic L. Z., Stamenovic B. A. Neuromodulation of synaptic transmission with thymopentin. Vojnosanitetski Pregled 1994; 51: 192–200
- Caruso C., Candore G., Modica M. A., Di Giulio C., Ingrassia A., Di Lorenzo G. In vitro thymopentin modulation of mitogen responsive T-cell precursor frequency. Thymus 1991; 14: 249–251
- Audhya T., Heaver G. A., Kroon D. J., Goldstein G. Cooperativity of thymopoietin 32–36 (the active site) and thymopoietin 38–45 in receptor binding. Regul. Pept. 1984; 9: 155–164
- Sundal E. Thymopentin in Cancer. Curr. Ther. Res. 1992; 51: 906–924
- Hu C., Radelli L., Scorza R., Bonara P., Perego R., Fantuzzi G. In vivo enhancement of NK-cell activity by thymopentin. Int. J. Immunopharmac. 1990; 12: 193–197
- Covelli V., Munno I., Altamura A., Pellegrino N. M., Decandia P., Jirillo E. Administration of thymopentin to patients with phobic disorders improves depressed phagocytotic functions. Immunopharm. & Immunotox. 1990; 12: 619–631
- Sundal E. Thymopentin and infection prophylaxis in cancer patients: A review. Int. J. Immunotherapy 1992; 8: 101–113
- Conant M. A., Calabrese L. H., Thompson S. E., Poiesz B. J., Rasheed S., Hirsch R. L., Meyerson L. A., Kremer A. B., Wang C. C., Goldstein G. Maintenance of CD4+ cells by thymopentin in asymptomatic HFV-infected subjects: results of a double-blind, placebo-controlled study. AIDS 1992; 6: 1335–1339
- Lazzarin A., Barcellini W., Foppa C. U., Borghi M. O., Franzetti F., Cinque P., Moroni M. Experiences with immunomodulant agents in HIV infections. Acta Haematologica 1987; 78: 84–90
- Weber P. J. A., Beck-Sickinger A. G. Comparison of the photochemical behavior of four different photoactivatable probes. J. Pept. Res. 1997; 49: 375–383
- Weber P. J. A., Bader J. E., Folkers G., Beck-Sickinger A. G. A fast and inexpensive method for N-terminal fluorescein-labeling of peptides. Bioorg. Med. Chem. Lett. 1998; 8: 597–600
- Towbin H., Staehelin T., Gordon I. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA 1979; 76: 4350–4354
- Sambrook J., Fritsch E. F., Maniatis T. Molecular cloning: a laboratory manualSecond Edition. Cold Spring Harbor Laboratory Press. 1989
- Hill C. S., Treisman R. Transcriptional regulation by extracellular signals: mechanisms and specifity. Cell 1995; 80: 199–211
- Traverse S., Gomez N., Paterson H., Marshall C., Cohen P. Sustained activation of the mitogen-activated protein (MAP) kinase cascade may be required for differentiation of PC 12 cells. Comparison of the effects of nerve growth factor and epidermal growth factor. Biochem. J. 1992; 288: 351–355
- Banchereau J., Steinman R. M. Dendritic cells and the control of immunity. Nature 1998; 392: 245–252
- Horton M. A. Blood cell biochemistry, Volume 5, Macrophages and related cells. Plenum Press, New York 1993